Facebook Linkedin Soundcloud Twitter Vimeo Xing
Home Tags NMTi

Tag: NMTi

World ADC 2023: Preclinical Data Validates NMTi as a Novel ADC...

ADC Review | Editorial Team
Results from a preclinical efficacy studies validates the N-Myristoyltransferase inhibitor (NMTi) payload platform, being developed by UK-based Myricx Bio, as a novel class of...
ADC Review, Journal of Antibody-drug Conjugates
ADC Review, Journal of Antibody-drug Conjugates (ISSN 2327-0152) is an international peer-reviewed publication designed to serve the needs of a diverse community of individuals including academia, life sciences, pharma, research, clinicians and physicians. Along with regulatory affairs, we also cover government authorities and representatives from payers to policymakers.

Latest

Peer Review

© 2013-2020 Sunvalley Communication, LLC. All Rights Reserved.

X